History of DiaSys Diagnostics Systems GmbH
DiaSys founded by Dr. Günther Gorka, Rolf Greiner and Dr. Manfred Probst.
Worldwide first liquid stable reagents for determination of enzymes and substrates in clinical chemistry.
DiaSys relocates to a proprietary building in Holzheim.
Launch of first turbidimetric tests.
Export activities start in 17 countries.
Introduction of CRP FS for inflammation testing.
TruLab line of quality control products.
Extensive expansion of reagent production capacity thanks to construction of a new building. Foundation of DiaSys France, the company's first subsidiary.
First joint venture in China. 1st international distributor meeting.
DiaSys enters instrument business with StarDust MC15 semi-automated analyzer.
First step into point-of-care testing with SensoStar glucose and lactate testing device.
Takeover of the clinical chemistry product activities of Merck KGaA, Darmstadt.
CRP U-hs - innovative reagent for universal and high sensitive testing.
Launch of reagents for food analysis.
Acquisition of shares in Rolf Greiner Biochemica GmbH.
Diabetes monitoring made easy with DiaSys oneHbA1c FS.
15 year anniversary
Foundation of DiaSys Russia and DiaSys Japan. Establishment of DiaSys Technologies for system development.
Acquisition of Poles France enhances the instrument platform for DiaSys reagents. pes diagnosesysteme in Leipzig joins DiaSys group.
New building at DiaSys headquarters.
Introduction of respons®920 fully automated analyzer for small and medium labs.
Acquisition of shares in Kovalent Ltd. in Brazil. Inauguration of DiaSys Diagnostic Products in Shanghai.
InnovaStar® - POC testing in lab quality.
Cooperation with JEOL Ltd. of Tokyo. Market launch BioMajesty® JCA-BM6010/C for higher throughputs - most compact and efficient.
In 2010 the second member of the respons® family was launched.
Celebrating 20 years DiaSys products with international distributor meeting.
Alliance with Proline setting up reagent production in Indonesia.
International Distributor Meeting in Dubai.
Joint venture with Leadman of Bejing, Rep. of China.
DiaSys acquires diagnostic division of Piramal, India reestablishing DiaSys India with sales, marketing, R&D, production and international business center for POCT QDx® brand.
DiaSys established subsidiary in U.S.A. Launch of respons®910VET for highest performance in veterinary diagnostics.
New QDx® point-of-care product line gives immediate results for prompt therapeutic decisions.
Participation in DiaServe laboratories. 25 years Choosing Quality.
DiaSys introduces a new enzymatic HbA1c assay - HbA1c net FS - for diagnosis and monitoring of diabetes.
DiaSys expands the respons®system family with the respons®940, a clinical chemistry random access analyzer with a throughput of 640 tests/h including ISE measurements.
Introduction of an immunoturbidimetric procalcitonin assay - Procalcitonin FS - for the diagnosis of sepsis.
DiaSys celebrates 30 years of ‘Choosing Quality’.
Introduction of a COVID-19 panel consisting of rapid tests and the immunoturbidimetric assay, SARS-CoV-2 UTAB FS, for the determination of SARS-CoV-2 total antibodies.
Foundation of a strategic partnership with ROBERT RIELE GmbH & Co KG, Berlin, for the exclusive marketing of the Photometer 505.